Synthesis, anticancer activities, antimicrobial activities and bioavailability of berberine-bile acid analogues

Letters in Drug Design and Discovery

Volumn 9, Issue 6, 2012, Pages 573-580

  Li, Qingyong ^a   He, Wuna ^a   Zhang, Li ^a   Zu, Yuangang ^a   Zhu, Qiaochu ^a   Deng, Xiaoqiu ^a   Zhao, Tengfei ^a   Gao, Wenqing ^a   Zhang, Baoyou ^a  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Anticancer; Antimicrobial; Berberine; Bile acids; Oral bioavailability; Synthesis

Indexed keywords

BERBERINE DERIVATIVE; BILE ACID;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACILLUS SUBTILIS; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SCREENING; DRUG SENSITIVITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIVER CELL; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS ALBUS; STAPHYLOCOCCUS AUREUS; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84861929315     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018012800673010     Document Type: Article

References (35)

1. A. Cho, E. Pharmacopoeia of the People's Republic of China, 5th ed.; China Medical Science and Technology Press: Beijing, 1990.
2. Jun, T.; Yibin, F.; Saiwah, T.; Ning, W.; Robert, C.; Youwei, W. Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J. Ethnopharmacol., 2009, 126, 5-17.
3. Rojsanga, P.; Mugdha, S.; Gritsanapan, W.; Seung, J. B. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett., 2007, 258, 230-240.
4. Zhibiao, Y.; Yan, Y.; Yizeng, L.; Bao, Z. Evaluation of the antimicrobial mode of berberine by LC/ESI-MS combined with principal component analysis. J. Pharm. Biomed. Anal., 2007, 44, 301-304. (Pubitemid 46551600)
5. Chili, K.; Chinwen, C.; Tsung, L. The anti-inflammatory potantial of berberine in vitro and in vivo. Cancer Lett., 2004, 203, 127-137.
6. Hardik, S. B.; Sudeep, S.; Dabashis, M.; Kamlesh, K. B.; Inder, P. S. Synthesis of 9-substituted derivatives of berberine as anti-HIV agents. Eur. J. Med. Chem., 2011, 46(4), 1045-1049.
7. Weijia, K.; Jing, W.; Parveen, A.; Meihong, L.; Satoru, I.; Cong, L.; Yanling, W.; Zizheng, W.; Shuyi, S.; Huaining, P.; Shukui, W.; Jingdan W.; Yue W.; Zhuorong L.; Jingwen L.; Jiandong J. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med., 2004, 10, 1344-1351.
8. Wenyan, H.; Li, D.; Yan, C.; Bin, G.; Jianchang, H.; Guili, X. Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry, J. Pharm. Biomed. Anal., 2007, 44, 931-937.
9. Pius, F.; Viness, P.; Valence, M. K. N.; Lisa, C. du T.; Yahya, E. C. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm. Drug Dispos., 2011, 32, 185-209.
10. Chun, Y.; Giridhar, S. T.; Ashim, K. Prodrug based optimal drug delivery via membrane transporter/receptor. Expert Opin. Biol. Ther., 2001, 1, 159-175.
11. Marie, V. S.-P.; Gerd, A. K.-U.; Bruno, H.; Peter, J. M. Transport of bile acids in hepatic and non-hepatic tissues. J. Exp. Biol., 2001, 204, 1673-1686.
12. Philippe, L.; Bertrand, C.; Fleur, L.; Folkert, K.; Bart, S. Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation. Physiol. Rev., 2009, 89, 147-191.
13. Kramer, W.; Wess, G. Bile acid transport systems as pharmaceutical targets. Eur. J. Clin. Invest., 1996, 26, 715-732. (Pubitemid 26308644)
14. Samrat, M.; Uday, M. Chemistry and biology of bile acids. Curr. Sci., 2004, 87, 1666-1683.
15. Elina, S. Exploitation of Bile Acid Transport Systems in Prodrug Design. Molecules, 2007, 12, 1859-1889.
16. Yinghong, L.; Yi, L.; Peng, Y.; Weijia, K.; Xuefu, Y.; Gang, R.; Hongbin, D.; Yueming, W.; Yanxiang, W.; Jiandong, J.; Danqing, S. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine. Bioorg. Med. Chem., 2010, 18, 6422-6428.
17. Jiyan, P.; Yong, Q.; Wenhua, C.; Guoan, L.; Zhihong, J. Synthesis and DNA-binding affinities of monomodified berberines. Bioorg. Med. Chem., 2005, 13, 5835-5840.
18. Huaming, S.; Zuojuan, X.; Junting, Y.; Jinhong, Z.; Hongbin, S. Synthesis of Novel Alkylamino Substituted cis and trans Apovincamate Derivatives. Chin. J. Nat. Med., 2011, 9, 51-57.
19. Yan, M.; Tianmiao, O.; Jiaheng, T.; Jinqiang, H.; Shiliang, H.; Lianquan, G.; Zhishu, H. Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: A new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene. Eur. J. Med. Chem., 2011, 46(5), 1906-1913.
20. Siritron, S.; Bongkot, T.; Nussara, M.; Gabriele, C.; Danuta, T.; Kim, L.; Apichart, S.; Therdsak, P.; Karina, C. G.; Jennifer, L. B.; John, B. B. Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg. Med. Chem., 2009, 17, 3866-3872.
21. Xiaoqing, W.; Xiao, Y.; Zhen'an, Z.; Tingting, T.; Kerong, D.; Irina, S.; Sigrid, F.; Said, J. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int. J. Antimicrob. Ag., 2009, 34(1), 60-66.
22. Qingyong, L.; Hongyan, L.; Yuangang, Z.; Zhenhuan, Q.; Liping, Y.; Lin, S.; Chen, L.; Limin, W. Synthesis and antitumor activity of novel 20s-camptothecin analogues. Bioorg. Med. Chem. Lett., 2009, 19(2), 513-515.
23. Michael, M. K.; Yugang, W.; Lei, H.; Jun, H.; Lele, L.; Fan, L.; Lijun, D. Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem. Toxicol., 2010, 48, 1105-1110.
24. Julio, J. C.; Juan L. M.; E. Rodr?guez-F. New organotropic compounds: Synthesis, characterization and reactivity of Pt (II) and Au (III) complexes with bile acids: DNA interactions and in vitro anticancer activity. J. Inorg. Biochem., 2003, 96(2-3), 311-320.
25. Ruchika, S.; Ferenc, M.; Vijaya, K. P.; Jun, W.; Ray, K.; Dermot, K. Bile acid toxicity structure-activity relationships: Correlations between cell viability and lipophilicity in a panel of new and known bile acids using an oesophageal cell line (HET-1A). Bioorg. Med. Chem., 2010, 18, 6886-6895.
26. Laïla, E. K.; Monique, C.; Marc-Antoine, B.; Géraldine, D. New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines. Bioorg. Med. Chem., 2008, 16, 8737-8744.
27. Dominique, B.; Laïla, E. K.; Monique, C.; Walae, S.; Mohamed, K.; Christos, R.; Sylvain, R. Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines. Eur. J. Med. Chem., 2010, 45, 2912-2918.
28. Criado, J. J.; Herrera, M. C.; Palomero, M. F.; Medarde, M.; Rodriguez, E.; Marin, J. J. Synthesis and characterization of a new bile acid and platinum(II) complex with cytostatic activity. J. Lipid Res., 1997, 38, 1022-1032. (Pubitemid 27255210)
29. Kramer, W.; Wess, G.; Schubert, G.; Bickel, M.; GirbigS, F.; Gutjahr, U.; Kowalewski, S.; Baringhaus, K. H.; Enhsen, A.; Glombik, H.; Mullner, S.; Neckermann, G. Liver-specific drug targeting by coupling to bile acids. J. Biol. Chem., 1992, 267, 18598-18604.
30. Ajoy, K. S.; Subhash, A.; Anupama, S. R. Evaluation of Berberine Chloride as a New Antibacterial Agent Against Gram-Positive Bacteria for Medical Textiles. Fibres & Text. East. Eur., 2011, 4(87), 131-134.
31. Atiq-ur-Rehman; Chunhong, L.; Loren, P. B.; Sarah, E. S.; Paul, B. S. Preparation of amino acid-appended cholic acid derivatives as sensitizers of Gram-negative bacteria. Tetrahedron Lett., 1999, 40, 1865-1868.
32. Kramer, W.; Stengelin, S.; Baringhaus, K.-H.; Enhsen, A.; Heuer, H.; Becker, W.; Corsiero, D.; Girbig, F.; Noll, R.; Weyland, C. Substrate specificity of the ileal and the hepatic Na+/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters. J. Lipid Res., 1999, 40, 1604-1617. (Pubitemid 29418701)
33. Baringhaus, K.-H.; Matter, H.; Stengelin, S.; Kramer, W. S. Substrate specificity of the ileal and the hepatic Na+/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na+/bile acid cotransporter. J. Lipid Res. 1999, 40, 2158-2168. (Pubitemid 30017517)
34. Anand, B.; James, E. P. Apical Sodium Dependent Bile Acid Transporter (ASBT, SLC10A2): A Potential Prodrug Target. Mol. Pharmacol., 2006, 3, 223-230.
35. A. F. Hofmann; L. R. Hagey. Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics.Cell. Mol. Life. Sci., 2008, 65, 2461-2483.